Home
Events that a source expects, grouped by the month, quarter or half-year the source names, with who expected each and when they said so.
Upcoming as of 2026-11-19 , the date this release was built (the newest input commit date), not today's date. An expected date is a statement by the source, not a result, and it can move. Dated events are on the timeline.
8,817 of these dates come from registry records: the start, primary completion or completion that a registry expects of a trial. A program assembled them, and a registry often leaves a date unchanged after it has passed. The calendar file lists the dates of written pages only.
Add to your calendar (calendar.ics)
The calendar file has one all-day event for each upcoming item. Where a source gives only a month, a quarter, a half-year or a year, the event sits on the first day of that period and its title says "expected sometime in" the period.
Upcoming
December 2028 250
2028-12-12
Study completion Venous Ethanol for Ventricular Tachycardia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05511246
2028-12-12
Study completion Edge-to-edge Mitral Valve Repair in ATTR-CM Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06075823
2028-12-15
2028-12-15
2028-12-15
Study completion Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07240467
2028-12-15
Primary completion Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07240467
2028-12-15
2028-12-15
2028-12-15
Primary completion Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07840365
2028-12-16
Study completion Digoxin After Acute Heart Failure (DIG-DICA) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07321509
2028-12-18
Study completion Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06486792
2028-12-18
Primary completion Stroke Prevention In Ischemic Stroke With Covert Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06486792
2028-12-19
2028-12-19
2028-12-20
2028-12-20
Study completion Efficacy and Mechanism of Yanjiu Needle for Pharyngeal Dysphagia Based on sEMG Features Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07656025
2028-12-28
2028-12-29
Study completion Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04755283
2028-12-30
2028-12-30
Study completion Non-invasive BCI-controlled Assistive Devices Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05183152
2028-12-30
Primary completion Non-invasive BCI-controlled Assistive Devices Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05183152
2028-12-30
2028-12-30
Study completion Colchicine in Chronic Kidney Disease Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06998862
2028-12-30
Primary completion Colchicine in Chronic Kidney Disease Patients Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06998862
2028-12-30
Study completion Synergistic Minimally Invasive Surgery and Deferoxamine in ICH Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07162363
2028-12-30
Primary completion Synergistic Minimally Invasive Surgery and Deferoxamine in ICH Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07162363
2028-12-30
2028-12-30
2028-12-30
2028-12-30
Study completion Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07275697
2028-12-30
Primary completion Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07275697
2028-12-30
2028-12-30
Primary completion ArcFlex Sheath in TAVR Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07320274
2028-12-30
2028-12-30
2028-12-30
2028-12-30
2028-12-30
Primary completion Study of YKYY032 Injection in Adults With Hyperlipoproteinemia (a) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07914660
2028-12-31
Study completion Molecular Imaging of Primary Amyloid Cardiomyopathy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT02641145
2028-12-31
Study completion SORT OUT X - Combo Stent Versus ORSIRO Stent Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03216733
2028-12-31
Primary completion Statins In Intracerbral Hemorrhage Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT03936361
2028-12-31
2028-12-31
2028-12-31
2028-12-31
2028-12-31
Primary completion Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04474223
2028-12-31
Study completion SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04776434
2028-12-31
2028-12-31
Study completion RADIANCE Continued Access Protocol Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05017935
2028-12-31
Primary completion RADIANCE Continued Access Protocol Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05017935
2028-12-31
Study completion Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05169021
2028-12-31
Study completion Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05180773
2028-12-31
Primary completion MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05487612
2028-12-31
2028-12-31
Study completion Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05679024
2028-12-31
2028-12-31
Study completion CSP #2026 - Beta Blocker Dialyzability on Cardiovascular Outcomes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05931276
2028-12-31
Study completion The MAGiC™ Cardiac Ablation European Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06019845
2028-12-31
2028-12-31
Primary completion The HEARTFELT Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06222099
2028-12-31
Study completion Enhanced External Counter Pulsation on Afterload Mismatch Rate in Post-TEER (PAMPER) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06227286
2028-12-31
Primary completion Enhanced External Counter Pulsation on Afterload Mismatch Rate in Post-TEER (PAMPER) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06227286
2028-12-31
2028-12-31
2028-12-31
Primary completion RAFT - Pace &Ablate Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06299514
2028-12-31
2028-12-31
2028-12-31
Study completion Avoiding Risks of Thrombosis and Bleeding in Surgery (ARTS) Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06523959
2028-12-31
Study completion Enhanced Community First Responder System Evaluation in Singapore Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06530433
2028-12-31
Primary completion Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06638944
2028-12-31
2028-12-31
2028-12-31
2028-12-31
2028-12-31
2028-12-31
Primary completion Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06773364
2028-12-31
Primary completion Thrombolysis in Factor Xa-inhibitors Trial Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06878066
2028-12-31
2028-12-31
2028-12-31
2028-12-31
2028-12-31
Study completion Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07035405
2028-12-31
Primary completion Colchicine for Secondary Prevention After Ischemic Stroke (CHANCE-3 EX) Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07035405
2028-12-31
Study completion Pulsed Field Ablation vs. Cryoballoon Ablation in Patients With Persistent Atrial Fibrillation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07064616
2028-12-31
Study completion Motor Learning in Health and Movement Disorders: Role of Physical Activity and Advanced Devices Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07066137
2028-12-31
Study completion Hebbian-Type Associative Stimulation in Stroke Rehabilitation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07085910
2028-12-31
Study completion Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07092709
2028-12-31
Study completion OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07137832
2028-12-31
Primary completion OPtimizing REperfusion by Primary Intra-Arterial ThRomboLysis for Medium Vessel Occlusion Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07137832
2028-12-31
Study completion Smart Technologies in Early Post-Stroke Rehabilitation Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07171073
2028-12-31
Primary completion Early Double Sequential Defibrillation in Out of Hospital Cardiac Arrest Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07174986
2028-12-31
Study completion Comparison of RA-IVL and RA-SHP in Calcified Coronary Lesions Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT07279987
2028-12-31
2028-12-31
Study completion Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT07324031
2028-12-31
2028-12-31
Study completion CAS for Stenosis With High-risk Features for CEA Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07370246
2028-12-31
Study completion Bivalirudin Versus Heparin During PCI in High Bleeding Risk Patients With Acute Coronary Syndromes Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07383155
2028-12-31
Study completion DNV001 Injection in Patients With Hypercholesterolemia Registry record
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT07391722
2028-12-31
2028-12-31
Overdue
The expected date has passed and no published record says the event happened. This does not mean it failed or was delayed: the atlas may not have checked the source since. Oldest first.
2024-12-31
Study completion Effect of Brain Stimulation on Stepping Performance in Stroke Survivors and Healthy Adults Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04437251
2024-12-31
Primary completion Effect of Brain Stimulation on Stepping Performance in Stroke Survivors and Healthy Adults Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04437251
2024-12
Study completion Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04504188
2024-12-31
Study completion Left Atrial Posterior Wall and PV Isolation Using Cryoballoon for Treatment of Persistent AF Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04505163
2024-12-31
Primary completion Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT04511468
2024-12-31
Primary completion Home-Based SolUtion for Remote Atrial Fibrillation Screening to PrevenT RecUrrence StrOke (HUA-TUO AF Trial) Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04523649
2024-12-31
Study completion Genotype-guided Strategy for Antithrombotic Treatment in Peripheral Arterial Disease. Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT04619927
2024-12
Study completion Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04654507
2024-12
Study start Effectiveness and Safety of the RIGHTEST Continuous Glucose Monitoring System for Blood Glucose Management in Persons With Diabetes Mellitus Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04838392
2024-12-31
Primary completion Randomized Study of Beta-Blockers and Antiplatelets in Patients With Spontaneous Coronary Artery Dissection Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04850417
2024-12
Study completion An E-health Intervention for Patients With Peripheral Artery Disease Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05029739
2024-12
Primary completion An E-health Intervention for Patients With Peripheral Artery Disease Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05029739
2024-12
Primary completion Chinese Herbal Medicine in Acute INtracerebral Haemorrhage (CHAIN) Trial Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05066620
2024-12
Primary completion Effect Of Semaglutide In Coronary Atheroma Plaque Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05071417
2024-12-31
Primary completion Blood Pressure and Lipids Reduction in High Risk Elderly Patients With Isolated Systolic Hypertension Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05165251
2024-12-31
Primary completion Folic Acid and Intensive Antihypertensive Therapy for Hypertension With CSVD Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05169021
2024-12-31
Study completion Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation Lesions Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05200637
2024-12-31
Primary completion Vascular Response of Orsiro vs. Xience Drug-Eluting Stents for Treating Coronary Bifurcation Lesions Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05200637
2024-12
Study completion Open Label RCT for Chronic Severe AR : Entresto vs. CCB/ARB Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05212597
2024-12-31
Primary completion Reducing Edema After intraCerebral Hemorrhage Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05263167
2024-12
Study completion A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05285436
2024-12
Primary completion A Prospective Clinical Study to Assess the Clinical Utility of Turbidity in Patients Using In-Home Peritoneal Dialysis Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05285436
2024-12-31
Study completion A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05318326
2024-12-31
Primary completion A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05318326
2024-12-31
Study completion Effects of Intraoperative Hemoperfusion on Acute Kidney Injury After Aortic Dissection Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05331495
2024-12-31
Primary completion Effects of Intraoperative Hemoperfusion on Acute Kidney Injury After Aortic Dissection Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT05331495
2024-12-31
Study completion Community Glucose Monitoring Project Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05351190
2024-12
Study completion A Trail of Drug-coated Balloon Treating Below The Knee Arterial Diseases Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05415995
2024-12
Study completion A Prospective, Multicenter Study to Evaluate the JensClip Transcatheter Valve Repair System Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05417945
2024-12
Study completion VIrtual Reality in Cognitive Rehabilitation of Processing Speed for Persons With ABI Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05443542
2024-12
Study completion Post-marketing Study in Femoral Popliteal Artery of Drug Coated Balloon Used for Treatment of Lower Limb Ischemia Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05498740
2024-12-31
Study completion Effect of UDCA on the New Onset Diabetes and Glucose Intolerance Induced by Statin Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05500937
2024-12-31
Primary completion Dapagliflozin Effect in Cognitive Impairment in Stroke Trial Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05565976
2024-12-31
Primary completion Statin and Bone Health Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05613400
2024-12
Study completion Clinical Validation and Safety of the AC 12L ECG System Against a Standard of Care 12-Lead ECG (AC 12L ECG) Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05617001
2024-12
Study completion AR Training Platform at Home Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05627050
2024-12
Primary completion AR Training Platform at Home Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05627050
2024-12-31
Primary completion Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT05632068
2024-12
Study completion Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05700266
2024-12
Primary completion Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05700266
2024-12
Primary completion Treatment of Chronic Post-stroke Oropharyngeal Dysphagia With Paired Stimulation Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05720871
2024-12
Study completion Semaglutide and Vascular Regeneration Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05870462
2024-12
Primary completion Semaglutide and Vascular Regeneration Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05870462
2024-12-31
Study completion A Multicenter Study to Evaluate the Effect of High Dose Rosuvastatin Versus Rosuvastatin and Ezetimibe in Stroke Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05884502
2024-12-31
Study completion Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05885919
2024-12-31
Primary completion Effect of Early Versus Late Initiation of Edaravone Dexborneol on Neural Function in Patients With Acute Ischemic Stroke Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05885919
2024-12-31
Primary completion Telemedicine in Atrial Fibrillation: Randomized Clinical Trial in Primary Care (AtrialConnect) Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05893199
2024-12-31
2024-12-31
2024-12-31
Primary completion Venus-Vitae Pivotal Study Smart-Align Study Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05991271
2024-12-31
Study completion Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06071949
2024-12-31
Study completion Long Term Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Central Neuropathy of Any Genesis Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06072001
2024-12
Study completion Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06078735
2024-12
Primary completion Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06078735
2024-12
Primary completion Efficacy of Songling Xuemaikang Capsules on Grade 1 Hypertension: a Randomized Controlled Trial Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06093932
2024-12
Study completion Study of the Efficacy and Safety of EPA in Patients With Type-2 Diabetes Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06129526
2024-12-31
2024-12
Study completion Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study) Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06197022
2024-12-31
2024-12-31
Primary completion Effectiveness and Safety of Coronary Scoring Balloon Dilation Catheter in the Pretreatment of Coronary Stenosis Lesions Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06291545
2024-12
Primary completion MCG for Localization of Tachyarrhythmia's Origin Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06327425
2024-12
Study completion The Impact of Different Feeding Modes on Patients With Intracerebral Hemorrhage Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06328946
2024-12
Primary completion The Impact of Different Feeding Modes on Patients With Intracerebral Hemorrhage Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-31 .
Source: ClinicalTrials.gov record NCT06328946
2024-12
Primary completion Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for Coronary Small Vessels Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06345209
2024-12-31
2024-12-31
2024-12-31
Primary completion BraiN20® Medical Device in Suspected Acute Stroke Patients Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06421337
2024-12-31
2024-12-31
2024-12-31
Primary completion Impact of Sleep Quality on Outcomes After Cardiac Surgery Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06527105
2024-12
Study completion Atrial Anomalies Predict Silent Atrial Fibrillation Detected by Implantable Cardiac Monitor in Cryptogenic Stroke Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06542770
2024-12
Study start Effect of Specific Mode Electroacupuncture Stimulation Combined with NGF on Dysphagia After Ischaemic Stroke: a Pilot Randomized Controlled Trial Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06737549
2024-12
Study start Clinical Trial Evaluating the Safety and Efficacy of Artificial Polymer Heart Valve for the Treatment of Aortic Valve Disease Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06737757
2024-12
Study start Clinical Trial of Ventiflow LP Supporting High-risk Percutaneous Coronary Intervention(PCI) Registry record
Expected 2024-12; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06754839
2024-12-31
Study start Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06760078
2024-12-31
Study start Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM Registry record
Expected 2024-12-31; that period ended on 2024-12-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06762223
2025-01-01
2025-01-01
Study completion ShOckwave ballooN or Atherectomy With Rotablation in Calcified Coronary Artery Lesions, the SONAR Trial Registry record
Expected 2025-01-01; that period ended on 2025-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05208749
2025-01-01
Primary completion ShOckwave ballooN or Atherectomy With Rotablation in Calcified Coronary Artery Lesions, the SONAR Trial Registry record
Expected 2025-01-01; that period ended on 2025-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05208749
2025-01-01
Primary completion Efficacy of Colchicine in Preventing Recurrent Stroke in the Patients With Acute Atherothrombotic Ischemic Stroke During Hospitalization Registry record
Expected 2025-01-01; that period ended on 2025-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06102720
2025-01-01
Primary completion Comparison of Expandable and Fixed Size Cryoballoon for the Treatment of Paroxysmal Atrial Fibrillation Registry record
Expected 2025-01-01; that period ended on 2025-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06183879
2025-01-01
Study start Beta-blockade in Unruptured Intracranial Aneurysm Registry record
Expected 2025-01-01; that period ended on 2025-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06249802
2025-01-01
Primary completion Clinical Impact of Orsiro™ Stent in Patient With Chronic Kidney Disease Registry record
Expected 2025-01-01; that period ended on 2025-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06475625
2025-01-01
Study start EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial) Registry record
Expected 2025-01-01; that period ended on 2025-01-01.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06762145
2025-01-06
Study start Evaluation of the Effectiveness and Safety of Remote Electrocardiographic Monitoring in Patients with Atrial Fibrillation Following Ablation Therapy Registry record
Expected 2025-01-06; that period ended on 2025-01-06.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06751459
2025-01-10
Primary completion A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities Registry record
Expected 2025-01-10; that period ended on 2025-01-10.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05872269
2025-01-15
Study start Parent Artery Reconstruction for Small Unruptured Cerebral Aneurusms Using Flow DiverTers: a Multicenter Randomized Trial(PARAT-MT) Registry record
Expected 2025-01-15; that period ended on 2025-01-15.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06600997
2025-01-19
Study completion Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation Registry record
Expected 2025-01-19; that period ended on 2025-01-19.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06632834
2025-01-19
Primary completion Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation Registry record
Expected 2025-01-19; that period ended on 2025-01-19.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT06632834
2025-01-21
Study completion Evaluation of the Safety and Efficacy of a Novel SeaLA™ Left Atrial Appendage Occluder Registry record
Expected 2025-01-21; that period ended on 2025-01-21.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05911685
2025-01-22
Study completion Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes Registry record
Expected 2025-01-22; that period ended on 2025-01-22.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05950516
2025-01-27
Primary completion Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients Registry record
Expected 2025-01-27; that period ended on 2025-01-27.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT06717685
2025-01
Study completion Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT02021006
2025-01
Primary completion The RISE Trial: A Randomized Trial on Intra-Saccular Endobridge Devices Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-11-18 .
Source: ClinicalTrials.gov record NCT03936647
2025-01-31
Primary completion MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention Registry record
Expected 2025-01-31; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT03961334
2025-01
Primary completion Iron Supplementation in TAVI and SAVR Patients With Iron Deficiency Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04786769
2025-01
Study completion Systematic Escalation of diuREtics With Natriuresis in Heart Failure Patients: SERENA Trial Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT04907123
2025-01
Study completion Rescues On Reperfusion Damage In Cerebral Infarction by Nelonemdaz Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05041010
2025-01
Study start MLC1501 Study Assessing Efficacy in STROke Recovery Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05046106
2025-01
Study completion Chinese Herbal Medicine in Acute INtracerebral Haemorrhage (CHAIN) Trial Registry record
Expected 2025-01; that period ended on 2025-01-31.
Date listed by U.S. National Library of Medicine (ClinicalTrials.gov), retrieved on 2026-10-26 .
Source: ClinicalTrials.gov record NCT05066620